Amicus Therapeutics: A Compelling Investment In The Rare Disease Biotech SectorSeeking Alpha • 08/16/24
Amicus Therapeutics (FOLD) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/09/24
Amicus Therapeutics (FOLD) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 08/08/24
Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate UpdatesGlobeNewsWire • 08/08/24
In NCLA Amicus Win, Federal Circuit Revives Lawsuit Against CDC's Illegal Eviction MoratoriumGlobeNewsWire • 08/08/24
NCLA Amicus Brief in NY Case Against Trump Explains Why NY's Executive Law Violates Free SpeechGlobeNewsWire • 08/02/24
In NCLA Amicus Win, Fifth Circuit Rules Against FCC's Unlawful Control of Universal Service FundGlobeNewsWire • 07/24/24
In NCLA Amicus Win, Supreme Court Upholds Small Business's Right to Judicial ReviewGlobeNewsWire • 07/01/24
In NCLA Amicus Win, Supreme Court Restores Americans' Rights to Trial by JuryGlobeNewsWire • 06/27/24
In NCLA Amicus Win, Fifth Circuit Upholds Permanent Block on Treasury's Illegal State Tax Cut BanGlobeNewsWire • 06/26/24
In NCLA Amicus Win, Supreme Court Overturns NLRB-Specific Preliminary Injunction StandardGlobeNewsWire • 06/13/24
In NCLA Amicus Win, Tenth Circuit Clears Path to Toppling Intrusive Dog Kennel Inspection RegimeGlobeNewsWire • 06/11/24
In NCLA Amicus Win, Fifth Circuit Topples SEC's Unlawful Effort to Regulate Private FundsGlobeNewsWire • 06/05/24
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewsWire • 06/05/24
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 05/10/24
Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/09/24
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate UpdatesGlobeNewsWire • 05/09/24